Our results reflected the pharmacological activity of the DCMF (200 mg/kg and 300 mg/kg) that exhibited the remarkable protective effects on ALI via the attenuations of inflammatory cytokines (TNF-α, IL-6, IL-β1 and MPO) and oxidative stress biomarkers (MDA), which are the side effects of LPS. The gene discussed is IL6; the disease is acute respiratory distress syndrome.